269 related articles for article (PubMed ID: 36346614)
21. Real-time analysis of the cancer genome and fragmentome from plasma and urine cell-free DNA using nanopore sequencing.
van der Pol Y; Tantyo NA; Evander N; Hentschel AE; Wever BM; Ramaker J; Bootsma S; Fransen MF; Lenos KJ; Vermeulen L; Schneiders FL; Bahce I; Nieuwenhuijzen JA; Steenbergen RD; Pegtel DM; Moldovan N; Mouliere F
EMBO Mol Med; 2023 Dec; 15(12):e17282. PubMed ID: 37942753
[TBL] [Abstract][Full Text] [Related]
22. A Highly Sensitive and Specific Non-Invasive Test through Genome-Wide 5-Hydroxymethylation Mapping for Early Detection of Lung Cancer.
Ren Y; Zhang Z; She Y; He Y; Li D; Shi Y; He C; Yang Y; Zhang W; Chen C
Small Methods; 2024 Mar; 8(3):e2300747. PubMed ID: 37990399
[TBL] [Abstract][Full Text] [Related]
23. Cancer signature ensemble integrating cfDNA methylation, copy number, and fragmentation facilitates multi-cancer early detection.
Kim SY; Jeong S; Lee W; Jeon Y; Kim YJ; Park S; Lee D; Go D; Song SH; Lee S; Woo HG; Yoon JK; Park YS; Kim YT; Lee SH; Kim KH; Lim Y; Kim JS; Kim HP; Bang D; Kim TY
Exp Mol Med; 2023 Nov; 55(11):2445-2460. PubMed ID: 37907748
[TBL] [Abstract][Full Text] [Related]
24. Multi-dimensional cell-free DNA-based liquid biopsy for sensitive early detection of gastric cancer.
Yu P; Chen P; Wu M; Ding G; Bao H; Du Y; Xu Z; Yang L; Fang J; Huang X; Lai Q; Wei J; Yan J; Yang S; He P; Wu X; Shao Y; Su D; Cheng X
Genome Med; 2024 Jun; 16(1):79. PubMed ID: 38849905
[TBL] [Abstract][Full Text] [Related]
25. Effects of blood-processing protocols on cell-free DNA fragmentomics in plasma: Comparisons of one- and two-step centrifugations.
Hu X; Zhang H; Wang Y; Lin Y; Li Q; Li L; Zeng G; Ou R; Cheng X; Zhang Y; Jin X
Clin Chim Acta; 2024 Jun; 560():119729. PubMed ID: 38754575
[TBL] [Abstract][Full Text] [Related]
26. A novel cell-free DNA methylation-based model improves the early detection of colorectal cancer.
Wu X; Zhang Y; Hu T; He X; Zou Y; Deng Q; Ke J; Lian L; He X; Zhao D; Cai X; Chen Z; Wu X; Fan JB; Gao F; Lan P
Mol Oncol; 2021 Oct; 15(10):2702-2714. PubMed ID: 33694305
[TBL] [Abstract][Full Text] [Related]
27. Urothelial Carcinoma Detection Based on Copy Number Profiles of Urinary Cell-Free DNA by Shallow Whole-Genome Sequencing.
Ge G; Peng D; Guan B; Zhou Y; Gong Y; Shi Y; Hao X; Xu Z; Qi J; Lu H; Zhang X; Zhan Y; Li Y; Wu Y; Ding G; Shen Q; He Q; Li X; Zhou L; Ci W
Clin Chem; 2020 Jan; 66(1):188-198. PubMed ID: 31811000
[TBL] [Abstract][Full Text] [Related]
28. Integrated 5-hydroxymethylcytosine and fragmentation signatures as enhanced biomarkers in lung cancer.
Hu X; Luo K; Shi H; Yan X; Huang R; Zhao B; Zhang J; Xie D; Zhang W
Clin Epigenetics; 2022 Jan; 14(1):15. PubMed ID: 35073982
[TBL] [Abstract][Full Text] [Related]
29. Plasma cfDNA methylation markers for the detection and prognosis of ovarian cancer.
Liang L; Zhang Y; Li C; Liao Y; Wang G; Xu J; Li Y; Yuan G; Sun Y; Zhang R; Li X; Nian W; Zhao J; Zhang Y; Zhu X; Wen X; Cai S; Li N; Wu L
EBioMedicine; 2022 Sep; 83():104222. PubMed ID: 35973389
[TBL] [Abstract][Full Text] [Related]
30. Hypomethylation in HBV integration regions aids non-invasive surveillance to hepatocellular carcinoma by low-pass genome-wide bisulfite sequencing.
Zhang H; Dong P; Guo S; Tao C; Chen W; Zhao W; Wang J; Cheung R; Villanueva A; Fan J; Ding H; Schrodi SJ; Zhang D; Zeng C
BMC Med; 2020 Aug; 18(1):200. PubMed ID: 32741373
[TBL] [Abstract][Full Text] [Related]
31. Early detection and stratification of colorectal cancer using plasma cell-free DNA fragmentomic profiling.
Zhou J; Pan Y; Wang S; Wang G; Gu C; Zhu J; Tan Z; Wu Q; He W; Lin X; Xu S; Yuan K; Zheng Z; Gong X; JiangHe C; Han Z; Huang B; Ruan R; Feng M; Cui P; Yang H
Genomics; 2024 Jun; 116(4):110876. PubMed ID: 38849019
[TBL] [Abstract][Full Text] [Related]
32. Read Count Patterns and Detection of Cancerous Copy Number Alterations in Plasma Cell-Free DNA Whole Exome Sequencing Data for Advanced Non-Small Cell Lung Cancer.
Jang H; Choi CM; Lee SH; Lee S; Jeong MK
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361723
[TBL] [Abstract][Full Text] [Related]
33. Pan-Cancer Detection and Typing by Mining Patterns in Large Genome-Wide Cell-Free DNA Sequencing Datasets.
Che H; Jatsenko T; Lenaerts L; Dehaspe L; Vancoillie L; Brison N; Parijs I; Van Den Bogaert K; Fischerova D; Heremans R; Landolfo C; Testa AC; Vanderstichele A; Liekens L; Pomella V; Wozniak A; Dooms C; Wauters E; Hatse S; Punie K; Neven P; Wildiers H; Tejpar S; Lambrechts D; Coosemans A; Timmerman D; Vandenberghe P; Amant F; Vermeesch JR
Clin Chem; 2022 Sep; 68(9):1164-1176. PubMed ID: 35769009
[TBL] [Abstract][Full Text] [Related]
34. Integrated fragmentomic profile and 5-Hydroxymethylcytosine of capture-based low-pass sequencing data enables pan-cancer detection via cfDNA.
Zhang Z; Pi X; Gao C; Zhang J; Xia L; Yan X; Hu X; Yan Z; Zhang S; Wei A; Guo Y; Liu J; Li A; Liu X; Zhang W; Liu Y; Xie D
Transl Oncol; 2023 Aug; 34():101694. PubMed ID: 37209526
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic analysis of cell-free DNA by fragmentomic profiling.
Zhou Q; Kang G; Jiang P; Qiao R; Lam WKJ; Yu SCY; Ma ML; Ji L; Cheng SH; Gai W; Peng W; Shang H; Chan RWY; Chan SL; Wong GLH; Hiraki LT; Volpi S; Wong VWS; Wong J; Chiu RWK; Chan KCA; Lo YMD
Proc Natl Acad Sci U S A; 2022 Nov; 119(44):e2209852119. PubMed ID: 36288287
[TBL] [Abstract][Full Text] [Related]
36. Multimodal analysis of cell-free DNA whole-methylome sequencing for cancer detection and localization.
Bie F; Wang Z; Li Y; Guo W; Hong Y; Han T; Lv F; Yang S; Li S; Li X; Nie P; Xu S; Zang R; Zhang M; Song P; Feng F; Duan J; Bai G; Li Y; Huai Q; Zhou B; Huang YS; Chen W; Tan F; Gao S
Nat Commun; 2023 Sep; 14(1):6042. PubMed ID: 37758728
[TBL] [Abstract][Full Text] [Related]
37. Noninvasive early differential diagnosis and progression monitoring of ovarian cancer using the copy number alterations of plasma cell-free DNA.
Chen L; Ma R; Luo C; Xie Q; Ning X; Sun K; Meng F; Zhou M; Sun J
Transl Res; 2023 Dec; 262():12-24. PubMed ID: 37499745
[TBL] [Abstract][Full Text] [Related]
38. Copy number variation in plasma as a tool for lung cancer prediction using Extreme Gradient Boosting (XGBoost) classifier.
Yu D; Liu Z; Su C; Han Y; Duan X; Zhang R; Liu X; Yang Y; Xu S
Thorac Cancer; 2020 Jan; 11(1):95-102. PubMed ID: 31694073
[TBL] [Abstract][Full Text] [Related]
39. A machine learning approach to optimizing cell-free DNA sequencing panels: with an application to prostate cancer.
Cario CL; Chen E; Leong L; Emami NC; Lopez K; Tenggara I; Simko JP; Friedlander TW; Li PS; Paris PL; Carroll PR; Witte JS
BMC Cancer; 2020 Aug; 20(1):820. PubMed ID: 32859160
[TBL] [Abstract][Full Text] [Related]
40. DNA methylation analysis of tumor suppressor genes in liquid biopsy components of early stage NSCLC: a promising tool for early detection.
Markou Α; Londra D; Tserpeli V; Kollias Ι; Tsaroucha E; Vamvakaris I; Potaris K; Pateras I; Kotsakis Α; Georgoulias V; Lianidou Ε
Clin Epigenetics; 2022 May; 14(1):61. PubMed ID: 35538556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]